Filing Flows › Dentsply Sirona (XRAY) › Q3 2026 › vs Q2 2026
Dentsply Sirona (XRAY) Q3 2026 vs Q2 2026 (quarter over quarter)
Dentsply Sirona's revenue fell $62.0M (-7%) from $898M in Q2 2026 to $836M in Q3 2026.
Dentsply Sirona, Q3 2026: revenue $836M (-8% year over year), operating margin 4.4%, net loss $3.0M, operating cash flow $32.0M. The chart draws each line against Q2 2026, the increases inside each band.
Margins
| Q3 2026 | Q2 2026 | Change | |
|---|---|---|---|
| Free cash flow margin | 0.0% | 6.1% | -6.1 pts |
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $836M | $898M | −$62.0M | -7% |
| Net loss | $3.0M | −$36.0M | $39.0M | — |
| Costs & expenses | $839M | $898M | −$59.0M | -7% |
| Operating costs | $799M | $816M | −$17.0M | -2% |
| Interest & other, net | $11.0M | $10.0M | $1.0M | +10% |
| Income tax | $29.0M | $36.0M | −$7.0M | -19% |
| Cost of revenue | $393M | $405M | −$12.0M | -3% |
| Research & development | $42.0M | $45.0M | −$3.0M | -7% |
| SG&A | $363M | $364M | −$1.0M | -0.3% |
| Operating cash sources | $90.0M | $94.0M | −$4.0M | -4% |
| Depreciation & amortization | $82.0M | $85.0M | −$3.0M | -4% |
| Share-based compensation | $8.0M | $9.0M | −$1.0M | -11% |
| Net loss absorbed | $3.0M | −$36.0M | $39.0M | — |
| Working capital & other | $55.0M | $31.0M | $24.0M | +77% |
| Operating cash flow | $32.0M | $99.0M | −$67.0M | -68% |
| Free cash flow (OCF − capex) | $0 | $55.0M | −$55.0M | -100% |
| Capital expenditures | $32.0M | $44.0M | −$12.0M | -27% |
Questions
How much did Dentsply Sirona's revenue grow quarter over quarter in Q3 2026?
Dentsply Sirona's revenue fell $62.0M (-7%) from $898M in Q2 2026 to $836M in Q3 2026.